Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells

Author:                        

Publisher: Spandidos Publications

ISSN: 1021-335X

Source: Oncology Reports, Vol.31, Iss.2, 2014-01, pp. : 983-988

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content